SIBO Symptoms: Signs, Causes, and How It Differs From IBS

SIBO stands for small intestinal bacterial overgrowth. The name is literal: bacteria that normally live in your colon migrate up into the small intestine, where they ferment carbohydrates too early in digestion. The result is bloating that gets worse through the day, gas that feels disproportionate to what you ate, and stool patterns that swing between loose and stuck.

It looks a lot like IBS. That's not a coincidence - one is often hiding inside the other. A meta-analysis of 37 studies found that 36.7% of people diagnosed with IBS test positive for SIBO (Shah et al., 2018).

What SIBO Actually Is

Your small intestine is the long middle section of your gut where most digestion and nutrient absorption happens. It's supposed to be relatively low in bacteria - typically fewer than 1,000 colony-forming units per milliliter of fluid. The colon, by contrast, holds trillions. The valve between them and the rhythmic contractions of the small bowel are what keep that gradient intact.

SIBO happens when bacteria slip through that line. According to the Mayo Clinic, the overgrowth is defined either as too many bacteria overall or the wrong type of bacteria in the small intestine. Once they're there, they ferment dietary sugars and starches before your body can absorb them, and that fermentation produces gas - mostly hydrogen, methane, or hydrogen sulfide.

The gas matters. The dominant gas determines what symptoms look like, which is why two people with SIBO can present completely differently.

The Core Symptoms

SIBO symptoms are non-specific, which is part of why it gets missed. The StatPearls clinical review lists the most common presentations:

Bloating and abdominal distension

This is the most consistent finding. People with SIBO often describe a flat stomach in the morning and a visibly distended abdomen by evening - sometimes mistaken for a "food baby," sometimes severe enough to need looser clothing by dinner. The bloating tracks with meals, especially meals heavy in fermentable carbs.

Excessive gas and belching

Flatulence and belching that seem out of proportion to what you ate. The bacteria are doing the work normally done by colonic flora, just in the wrong location, so fermentation byproducts hit you faster after meals.

Diarrhea, constipation, or both

Hydrogen-producing bacteria tend to drive looser stools and faster transit. Methane-producing archaea (technically these aren't bacteria - they're a separate domain called Archaea, and the condition is now classified as intestinal methanogen overgrowth, or IMO) slow gut motility and cause constipation. Many patients alternate between the two.

Abdominal pain and cramping

Often described as a deep ache or pressure, sometimes sharp. It tends to be worse after eating and can be relieved by passing gas or a bowel movement.

Nausea and early satiety

Feeling full after only a few bites. This is more common when SIBO coexists with gastroparesis or other motility issues.

Nutrient deficiencies and weight loss

In more advanced cases, the overgrown bacteria consume vitamin B12 and bile salts before your body can use them. The Merck Manual notes that this can lead to macrocytic anemia from B12 deficiency, fat malabsorption (steatorrhea), and unintentional weight loss. These are red-flag symptoms that warrant prompt workup.

Fatigue and brain fog

Often reported by SIBO patients but harder to pin to a clear mechanism. Likely a combination of B12 depletion, low-grade inflammation, and the gut-brain crosstalk that drives so much of how digestive disorders feel systemically. The gut-brain connection is a real, measurable pathway, not a metaphor.

SIBO vs IBS: The Honest Answer

Here's where it gets messy. SIBO and irritable bowel syndrome share most of their symptoms - bloating, gas, pain, altered bowel habits - and a large portion of people diagnosed with one have the other.

The cleanest way to think about it:

• IBS is a disorder of gut-brain interaction. The plumbing is normal; the signaling is not. The gut is hypersensitive to normal stretch, and motility patterns are dysregulated by a miscommunication between the enteric nervous system and the brain. The American College of Gastroenterology estimates IBS affects 10-15% of adults globally.
• SIBO is a microbial problem. There are too many of the wrong kind of bacteria in the wrong place. The mechanism is biological, not neurological.

The overlap is large. A 2018 meta-analysis pooling data from 25 studies found SIBO in 36.7% of IBS patients versus much lower rates in controls (Shah et al., 2018). With lactulose breath testing specifically, prevalence in IBS subjects was 62.3% versus 33.5% in controls; with glucose breath testing it was 20.7% versus 4.4%. The numbers vary widely with methodology, but the direction is consistent: SIBO is several times more common in people with IBS than in people without it.

That doesn't mean SIBO causes IBS, or vice versa. Yale Medicine's gastroenterology team has emphasized that treating SIBO often doesn't fully resolve IBS symptoms, because the underlying visceral hypersensitivity is still there. The reverse is also true: a patient with confirmed IBS may have SIBO driving a meaningful chunk of their symptoms, and a course of antibiotics can change the picture dramatically.

If you've been treated for IBS for years without much progress, asking your gastroenterologist about a breath test is reasonable. The signs of IBS overlap heavily with SIBO, and they're not always easy to tell apart on symptoms alone.

What Causes SIBO

SIBO is rarely random. It's almost always the downstream consequence of something else - a structural change, a motility problem, an immune issue, or a medication effect. The comprehensive review by Dukowicz et al. groups the causes into a few categories.

Impaired motility (the migrating motor complex)

Between meals, your small intestine runs a cleanup cycle called the migrating motor complex (MMC). It's a wave of muscular contractions that sweeps leftover food and bacteria toward the colon. When the MMC is weak or absent, bacteria linger and multiply. This is why conditions that damage gut nerves - diabetes (autonomic neuropathy), hypothyroidism, scleroderma, post-infectious IBS - dramatically raise SIBO risk.

Reduced stomach acid

Stomach acid is one of your first defenses against bacteria entering the small intestine. Long-term proton pump inhibitor (PPI) use blunts that defense. A meta-analysis of PPI users found SIBO prevalence of 36.8% among people on PPIs versus 19.9% in controls (Lo and Chan, 2013). The risk is duration-dependent: longer therapy, higher risk. That doesn't mean stop your PPI on your own - rebound acid hypersecretion is real and can be miserable - but it's worth a conversation about indication and duration.

Anatomic changes

Anything that creates a pocket where bacteria can hide raises risk. That includes surgical adhesions, prior bowel resection, gastric bypass, small bowel diverticula, fistulas, and strictures from Crohn's disease. A non-functioning ileocecal valve - the one-way gate between the small bowel and colon - is another structural culprit.

Immune deficiency

People with IgA deficiency, common variable immunodeficiency, or HIV are at elevated risk because secretory IgA in the small bowel is part of what keeps bacterial populations in check.

Other contributors

Chronic pancreatitis, cirrhosis, end-stage renal disease, and chronic opioid use all show up repeatedly in the SIBO risk literature. Per the StatPearls review, IBS, intestinal motility disorders, and chronic pancreatitis together account for 80-90% of SIBO cases.

How SIBO Is Diagnosed

The gold standard is a quantitative culture of fluid aspirated from the jejunum during endoscopy, with a threshold of more than 1,000 colony-forming units per mL. Almost nobody does this in clinical practice - it's invasive, the sample can be contaminated, and the bacteria that matter most don't always grow well in culture.

In the real world, doctors use breath tests. You drink a sugar solution (lactulose or glucose), then breathe into a tube at fixed intervals over 2-3 hours. If bacteria in the small intestine ferment the sugar, they release hydrogen or methane, which crosses into your bloodstream and gets exhaled.

The North American Consensus on breath testing (Rezaie et al., 2017) set the current cutoffs:

• Hydrogen: a rise of ≥20 ppm from baseline by 90 minutes is positive for SIBO
• Methane: a level of ≥10 ppm at any point during the test is positive (this defines IMO)
• Test doses: 75 g for glucose, 10 g for lactulose

Glucose is more specific (fewer false positives) but misses distal SIBO because it's absorbed in the upper small intestine. Lactulose travels further down the gut but produces more false positives. Most US gastroenterologists use lactulose; some prefer glucose. Neither test is perfect.

The 2020 ACG Clinical Guideline on SIBO notes that diagnostic accuracy of breath testing is limited, and recommends interpreting results in the context of symptoms, risk factors, and response to treatment - not as a stand-alone yes/no.

How SIBO Is Treated

Treatment has three parts: kill the overgrowth, fix the underlying cause, and rebuild.

Antibiotics

Rifaximin is the first-line antibiotic for hydrogen-dominant SIBO. It's non-absorbed, meaning it stays in the gut and has minimal systemic effects. Typical dose is 550 mg three times daily for 14 days. A meta-analysis pooling 32 studies found an overall eradication rate of approximately 70% with rifaximin (Gatta and Scarpignato, 2017). The 2020 ACG guideline recommends rifaximin for symptomatic patients with a positive breath test.

For methane-positive SIBO (IMO), rifaximin alone is less effective. Adding neomycin or metronidazole improves response, since methane-producing archaea are less susceptible to rifaximin as monotherapy.

Treat the underlying cause

If you don't fix what allowed the overgrowth in the first place, it tends to come back. Recurrence rates are not trivial - one frequently cited study put SIBO recurrence at 44% nine months after rifaximin treatment. So if it's PPI use, that's a conversation. If it's diabetic gastroparesis, glycemic control and prokinetics matter. If it's an anatomic issue, sometimes surgery is the answer.

Prokinetics and lifestyle

Low-dose prokinetics (prucalopride, low-dose naltrexone, ginger) are sometimes used to keep the migrating motor complex active and prevent recurrence. Spacing meals 3-4 hours apart and allowing a long overnight fast gives the MMC time to do its sweep - this is part of why general gut health practices like not snacking constantly actually matter at the mechanistic level.

Diet During and After SIBO Treatment

There's no single "SIBO diet" that fixes the underlying overgrowth - antibiotics or antimicrobials do that. But dietary approaches can reduce symptoms during treatment and support recovery afterward.

The most evidence-supported approach is a low-FODMAP diet, which restricts fermentable carbohydrates that feed the overgrown bacteria. It's a symptom-control strategy, not a cure - and it shouldn't be open-ended. The Monash University FODMAP team designed it as a three-phase elimination and reintroduction protocol, not a long-term restriction. We covered the mechanics in our low FODMAP diet guide.

Other approaches you'll see online - elemental diets, SIBO-specific diets that combine FODMAP and SCD principles, herbal antimicrobials - have varying levels of evidence. Elemental diets (predigested liquid nutrition) have decent data for SIBO eradication but are difficult to tolerate. Anything more restrictive should be done with a registered dietitian, not from a Reddit thread.

Who's at Highest Risk

SIBO prevalence in the general population is hard to pin down because most studies test symptomatic patients, not healthy populations. Estimates range from 2.5% to 22% in adults, depending on the testing method and population (Efremova et al., 2023).

The risk profile sharpens significantly in certain groups:

• Older adults: In one study, SIBO prevalence was 5.9% in younger adults versus 15.6% in older adults, driven by lower stomach acid and slower motility with age
• People on chronic PPIs: nearly 2x the risk of non-users
• Diabetics: autonomic neuropathy slows gut transit
• People with IBS: roughly 4-5x more likely than healthy controls
• Post-surgical patients: particularly after bowel resection or gastric bypass
• People with hypothyroidism, scleroderma, or chronic pancreatitis

When to See a Doctor

Bloating and gas alone aren't a medical emergency. But the combination of chronic GI symptoms with any of these warrants workup:

• Symptoms lasting more than a few weeks that don't respond to dietary changes
• Unintentional weight loss
• Anemia or known B12 deficiency without obvious cause
• Fatty, foul-smelling stools that float (steatorrhea)
• Blood in stool, fever, severe pain, or any of the alarm symptoms covered in our colorectal cancer warning signs guide
• Symptoms after abdominal surgery, especially bowel resection or bariatric surgery

A primary care doctor can run initial labs (CBC, B12, iron, celiac panel). A gastroenterologist is the right next step if SIBO is suspected, because they can order and interpret breath tests and rule out the conditions SIBO mimics: IBS, celiac disease, microscopic colitis, inflammatory bowel disease, exocrine pancreatic insufficiency.

The Tracking Argument

SIBO is a pattern condition. The bloating tracks with meals. Stool form swings with which gas dominates. Symptoms ebb when you eat low-fermentation, flare when you don't. Treatment response - and recurrence - shows up in the data before it shows up in how you feel.

A breath test is a snapshot. A two-week stool and symptom log is a movie. If you're working through a SIBO workup or post-treatment monitoring, the diary your gastroenterologist asks for is more useful when it's actually populated. Form, frequency, timing relative to meals, gas, pain, and bloating intensity are the variables that move the diagnostic needle.